Applicant, as named in the Orange Book

Cycle

Next listed expiry: Harliku on 10 Jun 2032. 4 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Harliku nitisinone	nitisinone	209449	10 Jun 2032	exclusivity
Nityr · 3 strengths nitisinone	nitisinone	209449	5 Jan 2035	patent
Tascenso Odt · 2 strengths fingolimod lauryl sulfate	fingolimod lauryl sulfate	214962	19 Jan 2036	patent
Cavhanza · 2 strengths nilotinib	nilotinib	217379	30 Apr 2041	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.